ASPARLAS
ASPARLAS
Approved
DIN Number
02542943
Drug Class
Human
Market Date
Oct 16, 2024
Company
HC
servier canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02542943
AIG Number0165262001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01 ANTINEOPLASTIC AGENTS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CALASPARGASE PEGOLActive
Strength: 3750 UNIT / 5 ML
Monograph: CALASPARGASE PEGOL